Showing results (1211-1220 of 1,245) with videos related to
Sort By:
Pageof 125
JAMA Network Open|September 18, 2023
Maintenance Therapy With Cetuximab After FOLFIRI Plus Cetuximab for RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical TrialValérie Boige, Hélène Blons, Eric François, et al.CNS Drugs|March 5, 2019
Risk of Acute Liver Injury in Agomelatine and Other Antidepressant Users in Four European Countries: A Cohort and Nested Case-Control Study Using Automated Health Data SourcesManel Pladevall-Vila, Anton Pottegård, Tania Schink, et al.Science Advances|December 10, 2025
Enhanced radiative cooling by large aerosol particles from wildfire-driven thunderstormsYaowei Li, John A Dykema, David A Peterson, et al.Oncotarget|October 26, 2016
The transfer of multigene panel testing for hereditary breast and ovarian cancer to healthcare: What are the implications for the management of patients and families?Marie Eliade, Jeremy Skrzypski, Amandine Baurand, et al.Physiological Genomics|May 29, 2008
Reliability, robustness, and reproducibility in mouse behavioral phenotyping: a cross-laboratory studySilvia Mandillo, Valter Tucci, Sabine M Hölter, et al.Journal of Clinical Apheresis|November 10, 2019
Therapeutic plasma exchange for neuromyelitis optica spectrum disorder: A multicenter retrospective study by the ASFA neurologic diseases subcommitteeTina S Ipe, Jay S Raval, Leonor P Fernando, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 27, 2021
Quality assurance program and early toxicities in the phase III BONBIS randomized trial evaluating the role of a localized radiation boost in ductal carcinoma in situCeline Bourgier, Didier Cowen, Florence Castan, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|October 19, 2025
Novel single-domain antibodies targeting a unique transferrin receptor 1 epitope for cross-species delivery of drugs in the central nervous systemMarion David, Romy Cohen, Diane Beuzelin, et al.Transfusion|March 10, 2025
Why do people still make anti-D over 50 years after the introduction of Rho(D) immune globulin? A Biomedical Excellence for Safer Transfusion (BEST) Collaborative studyRegina M DelBaugh, Michael F Murphy, Julie Staves, et al.Scientific Data|September 5, 2018
Single cell genomes of Prochlorococcus, Synechococcus, and sympatric microbes from diverse marine environmentsPaul M Berube, Steven J Biller, Thomas Hackl, et al.Pageof 125